Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2018 1
2019 1
2020 2
2021 1
2022 7
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence of cannabidiol (CBD) consumption and cancer patients' expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation.
Le Bozec A, Guédon M, Brugel M, Laurent M, Carlier C, Hettler D, Perrier M, Aubert L, Slimano F, Mongaret C, Bouché O. Le Bozec A, et al. Among authors: carlier c. J Oncol Pharm Pract. 2023 Jul 12:10781552231187136. doi: 10.1177/10781552231187136. Online ahead of print. J Oncol Pharm Pract. 2023. PMID: 37437182
Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN).
Brugel M, Marulier T, Evrard C, Carlier C, Tougeron D, Piessen G, Truant S, Turpin A, Williet N, Botsen D, Brasseur M, Perrier M, Bouché O. Brugel M, et al. Among authors: carlier c. Pancreatology. 2023 Sep;23(6):622-629. doi: 10.1016/j.pan.2023.06.010. Epub 2023 Jun 19. Pancreatology. 2023. PMID: 37394294
Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients.
Callon S, Brugel M, Botsen D, Royer B, Slimano F, Feliu C, Gozalo C, Konecki C, Devie B, Carlier C, Daire V, Laurés N, Perrier M, Djerada Z, Bouché O. Callon S, et al. Among authors: carlier c. Ther Adv Med Oncol. 2023 Jan 10;15:17588359221148536. doi: 10.1177/17588359221148536. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36643657 Free PMC article.
Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
Dupont M, Carlier C, Gower-Rousseau C, Barbier-Lider P, Botsen D, Brasseur M, Burgevin A, Chourbagi C, D'Almeida R, Hautefeuille V, Hentzien M, Lambert A, Lamuraglia M, Lavau-Denes S, Lopez A, Parent D, Slimano F, Brugel M, Bouché O. Dupont M, et al. Among authors: carlier c. BMC Cancer. 2022 Nov 25;22(1):1219. doi: 10.1186/s12885-022-10192-4. BMC Cancer. 2022. PMID: 36434607 Free PMC article.
Impact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis.
Laures N, Konecki C, Brugel M, Giffard AL, Abdelli N, Botsen D, Carlier C, Gozalo C, Feliu C, Slimano F, Djerada Z, Bouché O. Laures N, et al. Among authors: carlier c. Pharmaceutics. 2022 Oct 6;14(10):2119. doi: 10.3390/pharmaceutics14102119. Pharmaceutics. 2022. PMID: 36297556 Free PMC article.
16 results